Today: 12 March 2026
Nvidia Stock Near $186 Faces Fresh Test After $2 Billion Nebius Bet and Meta Chip Push
12 March 2026
2 mins read

Nvidia Stock Near $186 Faces Fresh Test After $2 Billion Nebius Bet and Meta Chip Push

NEW YORK, March 12, 2026, 09:04 EDT

Nvidia shares were on track for a softer open Thursday, with the AI chipmaker unveiling a $2 billion stake in cloud player Nebius. The stock hovered close to its $186.03 finish from Wednesday, keeping market cap steady at roughly $4.5 trillion. Premarket signals suggested a slight dip ahead of the bell. Yahoo Finance

This shift is significant: Nvidia’s ramping up the use of its balance sheet, aiming to steer the AI buildout rather than just feed it. Investors—despite a robust quarter—are still pushing management to consider returning more of Nvidia’s expanding cash reserves to shareholders, rather than plowing it all back into the broader AI landscape. Reuters

The squeeze is intensifying elsewhere. On Wednesday, Meta announced plans to roll out four generations of its own MTIA chips within the next two years, focusing a significant chunk on inference—the phase where AI models respond to users—even as it continues picking up hardware from Nvidia and AMD. “We see inference demand exploding at the moment,” Meta engineering executive Yee Jiun Song told Reuters. Reuters

Nvidia disclosed in a filing that it’s picking up an 8.3% stake in Nebius at $94.94 a share. Nebius, one of the so-called neoclouds—smaller players specializing in AI cloud services—has plans to push past 5 gigawatts of data-center capacity by 2030, according to the companies. CEO Jensen Huang described Nebius as “building an AI cloud designed for the agentic era.” Reuters

The Nebius news followed just a day behind Thinking Machines Lab’s announcement: the startup, helmed by ex-OpenAI tech chief Mira Murati, has signed a multiyear deal with Nvidia. The agreement brings in a financial investment from Nvidia and at least one gigawatt of Vera Rubin systems. According to Reuters, the deal might amount to around $50 billion worth of computing power, a figure that highlights Nvidia’s growing footprint as both a supplier and a financier. Reuters

Nebius isn’t the only big bet out there. Nvidia, for its part, announced earlier this month it would put $2 billion apiece into Lumentum and Coherent—moves aimed at locking down optical and networking tech for faster AI, and another clear indication the company isn’t holding back on shoring up its chip-centric hardware stack. Reuters

Nvidia’s results leave little room for doubt. The company posted record quarterly revenue of $68.1 billion in late February, with $62.3 billion of that coming from data-center products. For the current quarter, Nvidia projected revenue of $78 billion, give or take 2%. That estimate specifically leaves out any data-center compute sales from China. NVIDIA Investor Relations

The bull thesis isn’t as straightforward now. “The competitive picture is also shifting,” eMarketer analyst Jacob Bourne said after earnings, pointing out that Meta’s buying has started to include AMD, while top cloud players are pouring money into their own silicon. For Nvidia, that means robust sales could continue, but snapping up the next round of AI spending won’t come as easily. Reuters

Signals of competition aren’t slowing down. Last week, Broadcom—Meta’s partner on parts of its custom-chip projects—put a big number out there: it sees more than $100 billion in AI chip sales coming its way in 2027. At the same time, AMD’s supply deal with Meta signals the tech giants are splitting up their chip orders, avoiding dependence on one supplier. “Locking in supply,” is how Matt Britzman at Hargreaves Lansdown put it, as Meta looks to break from relying on a single provider. Reuters

Nvidia’s GTC conference is shaping up as the next key stop. Scheduled to kick off in San Jose on March 16, the event spotlights inference, “AI factories,” and next-gen infrastructure—the same hot-button issues investors have been dissecting in the wake of this week’s Nebius deal and Meta’s new chip roadmap. nvidia.com

Stock Market Today

  • Nintendo Shares Jump 18% as Surprise Hit 'Pokémon Pokopia' Boosts Switch 2 Sales Hopes
    March 12, 2026, 9:42 AM EDT. Nintendo's shares surged 18% this week following the unexpected success of "Pokémon Pokopia," which sold 2.2 million units in its first four days. The game, exclusive to the Switch 2 console launched last year, ranks as the fourth-best-selling title on the system. Investors are optimistic that this hit could accelerate Switch 2 sales, aligning with Nintendo's fiscal year sales forecast of 19 million units. Despite the rally, Nintendo's stock remains down about 28% over six months amid concerns over rising memory costs affecting margins. Analysts noted "Pokémon Pokopia" combines deep gameplay and multiplayer features, adding notable momentum to Nintendo's gaming lineup.

Latest article

Oracle Stock Price Jumps After AI Cloud Forecast Eases Debt Fears

Oracle Stock Price Jumps After AI Cloud Forecast Eases Debt Fears

12 March 2026
Oracle shares jumped 9.18% to $163.12 after the company raised its fiscal 2027 revenue target to $90 billion and reported a 325% surge in remaining performance obligations to $553 billion. Quarterly cloud revenue rose 44% to $8.9 billion. Oracle said many new AI contracts are backed by customer prepayments or client-supplied GPUs. Financing concerns remain despite $30 billion already raised toward a $50 billion target.
Why American Airlines Group Inc. Stock Is Stuck Near $11 as Oil Tops $100

Why American Airlines Group Inc. Stock Is Stuck Near $11 as Oil Tops $100

12 March 2026
American Airlines shares fell 0.6% to $11.04 Thursday as oil briefly topped $100 a barrel after new Gulf shipping attacks. Jet fuel prices have doubled since the Iran conflict began, squeezing airline margins. American is more exposed than rivals due to a lack of fuel hedging. The carrier will present at J.P. Morgan’s Industrials Conference on March 17.
Hims & Hers Health Stock Price Jumps Again as Novo Nordisk Truce Sparks Wall Street Upgrades

Hims & Hers Health Stock Price Jumps Again as Novo Nordisk Truce Sparks Wall Street Upgrades

12 March 2026
Hims & Hers Health shares climbed 5.1% to $27.19 in premarket trading Thursday, after closing up 10.3% Wednesday. The rally follows a deal with Novo Nordisk that ends a patent dispute and will return FDA-approved Wegovy and Ozempic to Hims’ platform later this month. Analysts raised targets but warned branded drugs may bring lower margins. Hims also disclosed an SEC probe and a Justice Department referral.
UiPath Stock Price Falls as 2027 Growth Outlook Overshadows Q4 Beat, $500 Million Buyback
Previous Story

UiPath Stock Price Falls as 2027 Growth Outlook Overshadows Q4 Beat, $500 Million Buyback

Hims & Hers Health Stock Price Jumps Again as Novo Nordisk Truce Sparks Wall Street Upgrades
Next Story

Hims & Hers Health Stock Price Jumps Again as Novo Nordisk Truce Sparks Wall Street Upgrades

Go toTop